Binge Eating Disorder
Conditions
Keywords
Binge Eating Disorder, Binge Eating, Eating Disorders, Obesity, Psychotherapy, Cognitive Behavioral Therapy
Brief summary
The purpose of the study is to test a newly developed individual psychotherapy treatment for binge eating disorder in adults. This treatment is a type of individual psychotherapy called Integrative Cognitive-Affective Therapy (ICAT) that focuses on helping people change their behaviors, feelings, thoughts about themselves, and relationships. This new treatment is being compared to an existing treatment called Cognitive-Behavior Therapy-Guided Self Help (CBTgsh), which focuses on changing behavior patterns through the use of reading and homework assignments along with sessions with a therapist. The primary hypothesis of this investigation is that ICAT will be associated with greater reductions in binge eating at end of treatment and follow-up compared to CBTgsh.
Interventions
BEHAVIORALIntegrative Cognitive-Affective Therapy
Integrative Cognitive-Affective Therapy is a psychotherapy treatment for binge eating that focuses on changing behaviors, feelings, thoughts, and relationships
BEHAVIORALCBT-Guided Self Help
CBT-Guided Self Help focuses on changing behavior patterns through the use of reading and homework assignments along with sessions with a therapist.
Sponsors
Neuropsychiatric Research Institute, Fargo, North Dakota
University of Minnesota
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Binge eating disorder (DSM-5)
Exclusion criteria
* History of gastric bypass surgery * Medical condition acutely affecting eating and/or weight * Current medical and/or psychiatric instability (e.g., acute suicidality) * Psychosis and/or bipolar disorder * Severe cognitive impairment or developmental disability * Inability to read English * Current substance use disorder * Current participation in psychotherapy and/or commercial weight loss program * Change in dosage and/or frequency of psychotropic medication in the past 6 weeks * Pregnant or breast feeding * BMI \< 21
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Binge Eating Episode Frequency (Eating Disorder Examination) | 17 Weeks and 6-month Follow-up | Frequency of binge eating as measured by the Eating Disorder Examination |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Global Eating Disorder Symptoms (EDE) | 17 Weeks and 6-month follow-up | Global Eating Disorder Symptoms as measured by the Eating Disorder Examination |
| Symptoms of Depression (BDI) | 17 Weeks and 6-month follow-up | Symptoms of Depression as measured by the Beck Depression Inventory |
| Symptoms of Anxiety (STAI) | 17 Weeks and 6-month Follow-up | Symptoms of Anxiety as measured by the State-Trait Anxiety Inventory |
| Self-Esteem (RSEQ) | 17 Weeks and 6-month Follow-up | Self-esteem as measured by the Rosenberg Self-Esteem Questionnaire |
Countries
United States
Outcome results
None listed